Skip to main content
. Author manuscript; available in PMC: 2010 Dec 1.
Published in final edited form as: Clin Cancer Res. 2009 Nov 17;15(23):7375–7380. doi: 10.1158/1078-0432.CCR-09-1910

Table 3.

Summary of anti-PSA antibody analysis.

Dose Vehicle Positive Antibody Titers
106 Aqueous 67% 1:20; 1:100
106 Matrix 0% --
107 Aqueous 50% 1:200
107 Matrix 0% --
108 Aqueous 57% 1:20 to 1:200
108 Matrix 30% 1:20 to 1:200
Aqueous – all doses 58%
Matrix – all doses 10%
All Patients 34%